# Coapt LLC, Chicago, IL – FDA Inspections

Source: https://www.keypedia.com/companies/coapt-llc/32959b76-e0c9-422d-92e7-d12579b7020c

> Inspection records and compliance data for Coapt LLC in Chicago, Illinois. 5 FDA inspections on record, 1 Form 483, last inspected October 28, 2024.

---

## Details

- Name: Coapt LLC
- FEI Number: 3010605876
- Address Line 1: 303 W Institute Pl Ste 200
- City: Chicago
- State: Illinois
- Zip Code: 60610
- Country Name: United States
- Address: 303 W Institute Pl Ste 200, Chicago, Illinois 60610, United States
- Country: United States

## Related Documents

- FDA Inspection 1254247 - Coapt LLC - 2024-10-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 28, 2024
- [FDA Inspection 1254247 - Coapt LLC - 2024-10-28](https://www.keypedia.com/records/fda_inspections/coapt-llc/98182a83-b192-40e6-ae63-184d3e084ce7) — classification: No Action Indicated (NAI), source: FDA, date: October 28, 2024
- FDA Inspection 1254247 - Coapt LLC - 2024-10-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 28, 2024
- FDA Inspection 1254247 - Coapt LLC - 2024-10-28 — classification: No Action Indicated (NAI), source: FDA, date: October 28, 2024
- [483 - Coapt LLC - 2022-11-02](https://www.keypedia.com/records/483/coapt-llc/af5464fa-05fd-4dfc-aa1b-f798c53b3ce3) — source: FDA, date: November 2, 2022
- FDA Inspection 1192137 - Coapt LLC - 2022-11-02 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 2, 2022
- [FDA Inspection 1192137 - Coapt LLC - 2022-11-02](https://www.keypedia.com/records/fda_inspections/coapt-llc/56ca79f5-4d5c-41b4-8ed1-76869bf07580) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 2, 2022
- [483 - Coapt LLC - 2019-12-11](https://www.keypedia.com/records/483/coapt-llc/65fca4fa-18f0-4555-b2fc-1a785980131e) — source: FDA, date: December 11, 2019
- FDA Inspection 1112400 - Coapt LLC - 2019-12-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 11, 2019
- FDA Inspection 1112400 - Coapt LLC - 2019-12-11 — classification: No Action Indicated (NAI), source: FDA, date: December 11, 2019
- FDA Inspection 988663 - Coapt LLC - 2016-09-20 — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2016
- FDA Inspection 903307 - Coapt LLC - 2014-11-14 — classification: No Action Indicated (NAI), source: FDA, date: November 14, 2014

## Related Companies

- [CNMC Company, Inc.](https://www.keypedia.com/companies/cnmc-company-inc/e9b17972-db25-41f6-b8a0-ea077d6ee24d)
- [Neurolumen LLC](https://www.keypedia.com/companies/neurolumen-llc/2e53eb6e-6247-4069-ade9-cef49b1b8f04)
- [Poiesis Medical, LLC](https://www.keypedia.com/companies/poiesis-medical-llc/03a8a2d5-3e29-45b1-9b42-c9df9d88ca8e)
- [Northwest Eye Design, LLC](https://www.keypedia.com/companies/northwest-eye-design-llc/eb08662b-92e1-4cb6-9dbf-f780fbf30a22)
- [EUSA Global, LLC](https://www.keypedia.com/companies/eusa-global-llc/746f9d01-d55f-4567-9125-2809cde3e900)
- [NeuroLogica Corporation](https://www.keypedia.com/companies/neurologica-corporation/112b8be4-8d99-4b9b-b6f8-0335d0ba9af0)
- [R&D Engineering, Inc. of Earlham](https://www.keypedia.com/companies/rd-engineering-inc-of-earlham/2f399ceb-79e5-476a-9bed-93247ecfebcd)
- [FHC, Inc.](https://www.keypedia.com/companies/fhc-inc/ad3d6d9e-f0ec-4265-83c6-9d06e50ca1da)
- [Draeger Medical Systems, Inc.](https://www.keypedia.com/companies/draeger-medical-systems-inc/361285bb-e4c9-4778-bd58-59caf9885b61)
- [Davryan Laboratories, Inc.](https://www.keypedia.com/companies/davryan-laboratories-inc/0dfc120f-19f4-418f-b184-f2fd358c6847)

## Related Officers

- [Recall Coordinator](https://www.keypedia.com/people/emma-schaefer/10299982-dce6-4fea-a3e9-8167030b0331)
- [Brittani N. Franklin](https://www.keypedia.com/people/brittani-n-franklin/1d5e9344-1145-42ff-a175-5541b565b15e)
